Nautilus Biotechnology Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Nautilus Biotechnology, Inc. (NAUT) Tops Q2 EPS by 5c
August 2, 2022 6:49 AM EDTNautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q2 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.
... More